Shri Ahimsa Naturals Ltd

Shri Ahimsa Naturals Ltd

₹ 150 -0.76%
09 May - close price
About

Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]

Key Points

Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.

  • Market Cap 351 Cr.
  • Current Price 150
  • High / Low 173 / 126
  • Stock P/E 18.8
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 31.1 %
  • ROE 25.0 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Promoter holding has decreased over last quarter: -25.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024
41
27
Operating Profit 14
OPM % 34%
1
Interest 0
Depreciation 1
Profit before tax 13
Tax % 26%
10
EPS in Rs 5.09
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
104 78
54 51
Operating Profit 50 27
OPM % 48% 34%
2 1
Interest 1 1
Depreciation 1 1
Profit before tax 51 25
Tax % 25% 26%
38 19
EPS in Rs 72.99 10.19
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -25%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -51%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Sep 2024
Equity Capital 5 18 19
Reserves 60 66 81
3 14 5
5 5 7
Total Liabilities 74 103 111
28 40 44
CWIP 4 8 5
Investments 0 0 0
42 56 62
Total Assets 74 103 111

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
20 6
-10 -17
-4 10
Net Cash Flow 7 -2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Debtor Days 39 53
Inventory Days 122 340
Days Payable 8 18
Cash Conversion Cycle 154 375
Working Capital Days 88 195
ROCE % 31%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2025Apr 2025
68.68% 68.68%
3.04% 3.04%
8.59% 8.59%
19.68% 19.68%
No. of Shareholders 2,3322,332

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents